Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis
View abstract on PubMed
Summary
This summary is machine-generated.High diacylglycerol kinase alpha (DGKα) expression in intrahepatic cholangiocarcinoma (ICC) correlates with poorer survival and increased recurrence. DGKα may serve as a prognostic biomarker and potential therapeutic target for ICC.
Area Of Science
- Oncology
- Cancer Biology
- Molecular Pathology
Background
- Intrahepatic cholangiocarcinoma (ICC) presents a significant clinical challenge due to high recurrence rates and poor patient prognosis.
- Effective prognostic biomarkers and therapeutic strategies for ICC are urgently needed.
- Diacylglycerol kinase alpha (DGKα) is implicated in hepatocellular carcinoma recurrence, but its role in ICC remains unexplored.
Purpose Of The Study
- To investigate the expression of DGKα in ICC tissues.
- To determine the correlation between DGKα expression and clinical features, patient survival, and recurrence.
- To evaluate DGKα as a potential prognostic biomarker and therapeutic target for ICC.
Main Methods
- Immunohistochemistry (IHC) was employed to assess DGKα expression in 69 ICC surgical specimens.
- DGKα expression was categorized and correlated with clinical parameters and patient outcomes.
- Ki-67 expression was evaluated as a marker of cell proliferation and its association with DGKα levels was examined.
Main Results
- DGKα expression was detected in a subset of ICC patients (DGKα+ group), who were generally older and presented with more advanced disease.
- Patients with DGKα+ ICC exhibited significantly worse overall survival and recurrence-free survival (RFS).
- DGKα positivity emerged as an independent prognostic factor for RFS, and higher DGKα levels correlated with increased Ki-67-positive cells, indicating enhanced proliferation.
Conclusions
- Pathological DGKα expression in ICC is associated with increased cancer cell proliferation and recurrence.
- DGKα may serve as a valuable prognostic biomarker for ICC.
- Targeting DGKα presents a potential therapeutic strategy for intrahepatic cholangiocarcinoma.
Related Concept Videos
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

